Literature DB >> 19723615

Impact of observer experience on the reproducibility of transient elastometry in HIV/HCV co-infected patients.

Karin Neukam1, Juan Macías, Concepción Ferrete, José C Palomares, Ana Fernández, José A Mira, Juan A Pineda.   

Abstract

BACKGROUND: Data on the influence of observer experience on transient elastometry (TE) in hepatitis C virus (HCV) infection are scarce, and there are no data on HCV/HIV co-infected patients.
METHODS: TE determination was conducted by an experienced and an inexperienced observer in 93 patients who were divided into three groups according to the chronological order of their attendance. The interobserver variability of TE results was analyzed by the intraclass correlation index (ICC) and the interobserver agreement of the classification of significant fibrosis and cirrhosis by the kappa index.
RESULTS: The overall ICC was 0.970 (95% confidence interval [CI] 0.954-0.980). For groups 1, 2, and 3, the ICCs were 0.952 (95% CI 0.901-0.977), 0.966 (95% CI 0.931-0.984), and 0.986 (95% CI 0.971-0.993), respectively. The kappa index for the classification of cirrhosis (cutoff value >or=14.6 kPa) for the three groups was 0.53, 1.00, and 0.91. The use of two cutoff points to exclude (<6 kPa) or diagnose significant fibrosis (>9 kPa) yielded a kappa index of 0.72, 1.00, and 1.00, respectively.
CONCLUSIONS: In HIV/HCV co-infected patients, the concordance between an inexperienced and an experienced observer is acceptable after a short instruction period. To maximize this concordance, a training period of 60 measurements should be recommended.

Entities:  

Mesh:

Year:  2009        PMID: 19723615     DOI: 10.1310/hct1004-276

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN: 1528-4336


  1 in total

1.  Intraobserver variability in fibroid size measurements: estimated effects on assessing fibroid growth.

Authors:  Malana Moshesh; Shyamal D Peddada; Tracy Cooper; Donna Baird
Journal:  J Ultrasound Med       Date:  2014-07       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.